• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GYNESONICS SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM; ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GYNESONICS SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM; ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM Back to Search Results
Model Number SONATA2-110
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Pelvic Pain (4865)
Date of Event 02/28/2024
Type of Reportable Event Serious Injury
Event or Problem Description
On (b)(6) 2024, a patient reported to gynesonics that she underwent a sonata treatment on (b)(6) 2024.She reported that she had moderate to severe pain for 8 days afterwards that was managed by prescription pain medicine.However, while the pain is no longer severe, she still having significant pain every day.She is taking tylenol and aleve but still averaging a 3 or 4 out of 10 on the pain scale daily.The daily pain is worse than my normal period pain was before the sonata treatment.Sometimes the pain gets up to a 5 or 6 out of 10.By contrast, her normal period cramps before the sonata rarely went above a 3 out of 10 on the pain scale.She also reported experiencing hot flashes that were severe after the surgery and now are moderate.
 
Additional Manufacturer Narrative
There was no report of device malfunction during the procedure and the system functioned as expected.Submission of this report is associated with the recent acquisition of gynesonics by hologic, inc.During the integration into hologic's adverse event reporting system and procedures, a review of historical adverse events was performed.As a result this event was identified as being reportable on aug 12, 2025 and is being reported retroactively out of an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM
Common Device Name
ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM
Manufacturer (Section D)
GYNESONICS
200 cardinal way #250
redwood CA 94063
Manufacturer (Section G)
GYNESONICS
200 cardinal way #250
redwood city CA 94063
Manufacturer Contact
timothy rossi
200 cardinal way #250
redwood, CA 94063
6502416115
MDR Report Key22964009
Report Number3005875675-2025-00044
Device Sequence Number9150978
Product Code KNF
UDI-Device Identifier10817929020326
UDI-Public(01)10817929020326
Combination Product (Y/N)N
Initial Reporter StateOK
Initial Reporter CountryUS
PMA/510(K) Number
K233848
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberSONATA2-110
Device Catalogue NumberSONATA2-110
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/28/2024
Initial Report FDA Received Date09/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-